Over the past few years, the issue of whether the description of a European patent or application should be amended…
了解更多
Over the past few years, the issue of whether the description of a European patent or application should be amended…
了解更多A Briefing Paper Antibodies and their derivatives, including bispecific and multispecific antibodies, fragments, and fusion products, have become central to…
了解更多The EPO’s Enlarged Board of Appeal (EBA) have issued their decision on G 1/23, providing further clarity to attorneys, patentees and…
了解更多The Unified Patent Court (UPC) allows granted European patents to be enforced or challenged centrally and for a single ruling…
了解更多Following the SkyKick v. Sky decision – which we covered in an earlier article – the key takeaway was that…
了解更多The EPO’s Enlarged Board of Appeal (EBA) has now issued their decision on G1/24 the referral relating to claim interpretation…
了解更多This article was originally commissioned and published in CITMA’s online blog, May 2025 Thom Browne and Adidas: two global names…
了解更多The European Patent Office (EPO) has recently issued the 2024 edition of its annual Patent Index which provides a detailed overview…
了解更多Now that we are into 2025 the European Patent Office (EPO) has recently issued the 2024 edition of its annual Patent…
了解更多Intention to use it or lose it? Trainee trade mark attorney Joe Gargano explains that while Sky and SkyKick settled…
了解更多Applications for registered EU designs can be filed at the EUIPO and offer a convenient, cost-effective way of obtaining design…
了解更多The Unified Patent Court (UPC) has issued its first decision on patent infringement by equivalence in Plant-e Knowledge B.V. &…
了解更多